About
Pharnext esPharnext is an advanced, clinical-stage biopharmaceutical company founded by renowned scientists and entrepreneurs including Professor Daniel Cohen, a pioneer in modern genomics. Pharnext has two lead products in clinical development. PXT3003 is currently in an international Phase 3 trial for the treatment of Charcot-Marie-Tooth disease type 1A and benefits from orphan drug status in Europe and the Unit...
- Website
- Headquarters
- Industries
- Employees11-50
- Social
Photos
Add photos to showcase Pharnext’s culture
Values
Add Pharnext’s values
Insider experiences
Share your experience of working at Pharnext
Org chart
View org chartTeams
View all (0)Add your teams to show how people work together at Pharnext
Jobs
View all (0)Add jobs to your org chart to show candidates who they’ll work with
Wires
View all (0)Publish company announcements to get more exposure